Structure Therapeutics In... (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

27.09

-0.24 (-0.88%)

At close: May 02, 2025, 3:59 PM

27.93

3.10%

After-hours: May 02, 2025, 05:42 PM EDT

Structure Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Mar 31, 2022	Dec 31, 2021
Cash & Equivalents	169.51M	172.13M	381.63M	97.83M	129.79M	50.64M	40.59M	126.49M	26.09M	28.09M	-107.31M	105.31K
Short-Term Investments	714.01M	743.16M	545.49M	338.61M	337.53M	154.79M	184M	114.37M	64.75M	74.66M	214.61M	2K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-74.58M	n/a	n/a
Other Long-Term Assets	5.11M	1.82M	1.83M	47K	45K	350K	38K	59K	3.46M	76.85M	-107.31M	111.00
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	7.69M	8.37M	10.5M	n/a	6.29M	4.54M	3.63M	5.29M	2.25M	n/a	n/a	n/a
Total Current Assets	891.21M	923.65M	937.62M	449.36M	473.61M	209.96M	228.22M	246.16M	93.09M	104.77M	107.31M	109.25K
Property-Plant & Equipment	7.01M	7.74M	7.58M	7.82M	8.36M	6.06M	1.17M	1.14M	1.29M	1.37M	n/a	1.79K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.12M	9.57M	9.41M	7.86M	8.41M	6.41M	1.21M	1.2M	4.76M	3.64M	-107.31M	1.91K
Total Assets	903.33M	933.22M	947.03M	457.22M	482.02M	216.37M	229.43M	247.35M	97.84M	108.41M	n/a	111.16K
Account Payables	8.02M	8.45M	2.21M	6.54M	4.74M	3.32M	5.7M	4.95M	6.01M	5.7M	n/a	3.48M
Deferred Revenue	n/a	n/a	n/a	297K	356K	n/a	n/a	n/a	n/a	n/a	n/a	-3.48M
Short-Term Debt	n/a	n/a	n/a	n/a	1.44M	n/a	n/a	n/a	260K	n/a	n/a	n/a
Other Current Liabilities	7.29M	23.14M	41K	297K	12.44M	580K	176K	104K	3.28M	147K	n/a	-8.42M
Total Current Liabilities	36.02M	33.43M	22.66M	23.59M	24.74M	20.09M	15.01M	11M	13.01M	12.23M	n/a	8.66K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	302K	309K	293K	295.96K	298K	281K	n/a	n/a	n/a	200.09M	n/a	-104.77K
Total Long-Term Liabilities	2.47M	2.98M	3.34M	3.82M	4.31M	3.31M	1K	5.11M	199.97M	200.09M	n/a	167.23K
Total Liabilities	38.49M	36.42M	26M	27.41M	29.05M	23.41M	15.01M	11M	212.99M	212.32M	n/a	175.89K
Total Debt	3.86M	4.38M	4.67M	5.12M	5.45M	3.85M	73K	168K	260K	330K	n/a	621.00
Common Stock	17K	17K	17K	14K	14K	11K	10K	11K	1K	1K	n/a	1.00
Retained Earnings	-329.1M	-292.62M	-258.64M	-232.61M	-206.57M	-182.07M	-158.21M	-134.93M	-116.95M	-105.08M	n/a	-64.74K
Comprehensive Income	914K	2.84M	-487K	-90K	521K	-310K	-390K	147K	-110K	-135K	-64.73M	-166.96M
Shareholders Equity	864.84M	896.8M	921.03M	429.81M	452.97M	192.96M	214.41M	236.35M	-115.14M	-103.91M	102.22M	-64.73K
Total Investments	714.01M	743.16M	545.49M	338.61M	337.53M	154.79M	184M	114.37M	64.75M	74.66K	214.61M	2K